公开(公告)号：WO2005023292A1

公开(公告)日：2005-03-17

申请号：PCT/US2004/028746

申请日：2004-09-03

Applicant: THE GENERAL HOSPITAL CORPORATION ,  INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) ,  LOMPR, Anne-Marie ,  LIPSKAIA, Larissa ,  MONTE, Federica, Del ,  HAJJAR, Roger, J.

Inventor： LOMPR, Anne-Marie ,  LIPSKAIA, Larissa ,  MONTE, Federica, Del ,  HAJJAR, Roger, J.

IPC: A61K38/46

CPC classification number: C12N15/86 ,  A61K38/00 ,  A61K48/00 ,  A61K48/005 ,  A61L33/128 ,  C12N9/14 ,  C12N2710/10343 ,  C12Y306/03008

Abstract: Restenosis in a subject can be treated by administering to a tissue, e.g., a blood vessel, of the subject an agent that increases SERCA activity. For example, a stent that is coated with the agent can be introduced into a blood vessel.

Abstract translation: 可以通过向受试者的组织（例如血管）施用增加SERCA活性的药物来治疗受试者的再狭窄。 例如，可以将涂有该药剂的支架引入血管。